Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

Clinical trial NCT00252564 · COMPLETED

Trial details

NCT number: NCT00252564
Sponsor: US Oncology Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2005-09-01
Primary completion: 2007-06-01
Enrollment: 247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.